# Alzamend Neuro Inc (ALZN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ALZN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -8.77M | $ -8.07M | $ 0 | $ 733.2K |
| 2025 | $ 0 | $ -4.62M | $ -7.03M | $ 0 | $ 3.97M |
| 2024 | $ 0 | $ -10.46M | $ -8.85M | $ 300.7K | $ -2.59M |
| 2023 | $ 0 | $ -16.09M | $ -9.65M | $ 0 | $ 3.05M |
| 2022 | $ 0 | $ -13.81M | $ -7.51M | $ 0 | $ 13.35M |
| 2021 | $ 0 | $ -6.00M | $ -3.22M | $ 335.3K | $ 2.01M |
| 2020 | $ 0 | $ -5.62M | $ -2.99M | $ 62.7K | $ 821.7K |
| 2019 | $ 0 | $ -6.28M | $ -1.35M | $ 79.3K | $ 316.9K |
| 2018 | $ 0 | $ -1.23M | $ -2.71M | $ 0 | $ 2.32M |
| 2017 | $ 319.2K | $ -2.11M | $ -1.91M | $ 591.3K | $ -584.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 1.84 |
| Current Ratio | 1.31 |

## Other views

- [Metrics](https://sponda.capital/en/ALZN.md)
- [Charts](https://sponda.capital/en/ALZN/charts.md)
- [Compare](https://sponda.capital/en/ALZN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.